Drug Trial Radar · NCT01426269
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo
Last checked: Nov 20, 2026Latest source record: Aug 1, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
235
Actual
Start
Sep 2011
Primary completion
Jun 2013
Study completion Jun 2013
Sponsor
- Lead sponsor
- Galderma R&DIndustry
- Sponsor type
- Industry
- First posted
- Aug 31, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess relapse, efficacy and safety in subjects with rosacea during long-term treatment with either Oracea® or placebo, after an initial 12-week regimen of Oracea® and MetroGel® 1%.
Conditions
- Rosacea
Interventions
DoxycyclineDrug
During phase 1 (baseline - week 12): Oracea (doxycycline 40 mg USP (30 mg immediate release \& 10 mg delayed release beads)), oral, one capsule daily in the morning During phase 1 (baseline - week 12) and phase 2 (week 12 - week 52): Oracea (doxycycline 40 mg USP (30 mg immediate release \& 10 mg delayed release beads), oral, one capsule daily in the morning
MetronidazoleDrug
During Phase 1: MetroGel 1% (metronidazole 1% gel), topical, apply a thin layer once daily to the affected area
PlaceboDrug
During phase 2 (week 12 - week 52): placebo, oral, one capsule daily in the morning
Primary outcomes
What the sponsor says the trial is designed to measure.
- Period 2: Number of Subjects Who RelapsedTime frame: Period 2 (40 weeks)
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
ATS Clinical Research
Santa Monica, California
Dadeland Dermatology
Coral Gables, Florida
Melissa L. F. Knuckles M.D., P.S.C.
Corbin, Kentucky
Dermatology Specialists Research
Louisville, Kentucky
Melissa L. F. Knuckles M.D., P.S.C.
Richmond, Kentucky
The Maryland Laser, Skin, and Vein Institute, LLC
Hunt Valley, Maryland
Grekin Skin Institute
Warren, Michigan
Hilary Baldwin
Brooklyn, New York
The Center for Dermatology at Linden Oaks
Rochester, New York
Brodell Medical, Inc.
Warren, Ohio
Center for Dermatology and Laser Surgery
Portland, Oregon
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.